Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial
European paediatric Soft tissue sarcoma Study Group
Research output: Contribution to journal › Article › peer-review
115Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial'. Together they form a unique fingerprint.